In addition to
Fogarty-supported programs and the collaborations Fogarty is involved in, many Institutes and Centers at NIH offer funding opportunities to support research on global health topics, or in areas relevant to global health.
Global health funding opportunities from other NIH Institutes & Centers
Title
| Notice Number | Expiration date |
|---|
|
Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments | NOT-CA-22-038 | May 8, 2024
|
|
Notice of Special Interest (NOSI) in Reducing Suicide Risk in Young People in Low- and Middle-Income Countries and Low-Resource Settings | NOT-MH-21-090 | May 8, 2024
|
| Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (R01 Clinical Trial Not Allowed) | RFA-AI-24-010 | June 29, 2024 |
|
Limited Interaction Targeted Epidemiology: Epidemiology of Transmission and Treatment of HIV Among People Who Are at Increased Risk for HIV Infection in Latin America (LITE-LA) (UG3/UH3 Clinical Trial Optional) | RFA-AI-24-009 | July 31, 2024
|
|
Notice of Special Interest (NOSI): Administrative Supplements for NCI Global Oncology Mentored Research | NOT-CA-24-028 | May 16, 2024
|
|
Streamlining mental health interventions for youth living with HIV in Low- and Middle-Income Countries (R01 Clinical Trial Optional)) | RFA-MH-25-140 | August 13, 2024 |
NIMH Research Education Mentoring Program for HIV/AIDS Researchers (R25 Clinical Trial Not Allowed)
Note: NIMH encourages U.S.-based applications with Low- and Middle-Income Country (LMIC) sites. | PAR-21-228 | September 8, 2024 |
|
International Research in Infectious Diseases (R01 Clinical Trial Not Allowed) | RFA-AI-23-023 | August 2, 2025
|
|
Notice of Special Interest: Administrative Supplements for the U.S.-Japan Brain Research Cooperative Program (BRCP) - U.S. Entity (Admin Supp) | NOT-NS-23-092 | September 19, 2025 |
Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)
| PAR-22-256 | November 18, 2025
|
|
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional) | PAR-23-191 | December 9, 2025 |
|
Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional) | PAR-23-190
| December 23, 2025 |
|
Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) | PAR-23-300
| March 14, 2026 |
Notice of Special Interest (NOSI):
Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets
| NOT-MH-23-275 | September 8, 2026 |
Notice of Special Interest (NOSI):
Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets
| NOT-MH-23-275 | September 8, 2026 |
Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed)
| PAR-23-303 | January 7, 2027 |
|
Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required) | PAR-23-304
| January 7, 2027 |
Notice of Special Interest (NOSI):
Advancing Rheumatic Heart Disease Research (R01)
| NOT-HL-23-106 | January 8, 2027 |
Other NIH global health funding resources
Subscribe to Fogarty's
Global Health Matters newsletter, and weekly
funding news for global health researchers
Subscribe
NIH Career Development Opportunities for Global Health Researchers
Updated April 17, 2024